Bio
Christina Curtis, PhD, MSc is the RZ Cao Professor of Medicine, Genetics and Biomedical Data Science at Stanford University where she also serves as Senior Vice Chair of Research in the Department of Medicine and Director of Artificial Intelligence and Cancer Genomics at the Stanford Cancer Institute. Dr. Curtis leads a federally-funded research laboratory focused on AI/ML, computational modeling, high-throughput molecular profiling and experimentation to develop new ways to prevent, diagnose and treat cancer. Her research redefined the molecular map of breast cancer and led to new paradigms in understanding the origins of human cancers, as well as how they evolve and metastasize. Dr. Curtis has been the recipient of numerous awards, including the National Institutes of Health (NIH) Director's Pioneer Award (2018) and the American Association for Cancer Research (AACR) Award for Outstanding Achievement in Basic Science (2022). She received the 2024 AACR-Breast Cancer Research Foundation (BCRF) Award for Outstanding Achievement in Breast Cancer Research and the Susan G. Komen Brinker Award, as well as the 2025 European Society for Molecular Oncology (ESMO) Translational Award and the Paul Marks Prize for Cancer Research. She is a Kavli Fellow of the National Academy of Sciences, a Susan G. Komen Scholar, and a Chan Zuckerberg Biohub Investigator. Dr. Curtis has served as a member of Board of Reviewing Editors at Science, and as a member of the Board of Directors of AACR and Stand Up 2 Cancer (SU2C). She is a scientific advisor to biopharma (Astrazeneca, Genentech, Bristol Myers Squibb, Pfizer), biotech and to VC firms.
